Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CERILLIANT™ Methyl-D3-malonic acid Solution, 1.0 mg/mL in Acetonitrile, Sold by MilliporeSigma™ Supelco™

Catalog No. 01001617 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-001-617 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-001-617 Supplier MilliporeSigma Supelco Supplier No. M1051ML
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Certified reference material

Methylmalonic acid, a malonic acid derivative, is a vital intermediate in the metabolism of fat and proteins and plays a key role in energy metabolism. Elevated methylmalonic acid levels can be caused by an inborn error of metabolism leading to methylmalonic aciduria or indicate early vitamin B<sub>12</sub> defficiency. This internal standard is suitable for quantitation of methylmalonic acid levels by LC/MS or GC/MS in newborn screening and clinical testing applications to test for methylmalonic acidemia and diagnose vitamin B<sub>12</sub> defficiency.
TRUSTED_SUSTAINABILITY

Specifications

CAS 75-05-8, 42522-59-8
Linear Formula C4H3O4D3
UN Number UN 1648 3 / PGII
Concentration 1.0 mg/mL in acetonitrile
Formula Weight 121.11
Packaging Ampule
Quantity 1 mL
Flash Point 2°C (35.6°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.